Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation

Published:2020-10-08 Issue:10 Volume:3 Page:e2017652
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Wang Jing¹²,Zhou Min¹,Xu Jing-Yan¹,Zhou Rong-Fu¹,Chen Bing¹,Wan Yuan²

Affiliation:

1. Department of Hematology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

2. The Pq Laboratory of Micro/Nano BiomeDx, Department of Biomedical Engineering, Binghamton University – SUNY, Binghamton, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2771516/wang_2020_oi_200635_1601603706.72996.pdf

Reference95 articles.

1. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.;Maertens;J Antimicrob Chemother,2018

2. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.;Wang;Med Oncol,2010

3. Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.;Xu;Eur Rev Med Pharmacol Sci,2016

4. Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.;Bow;BMC Infect Dis,2015

5. Conceptual and technical challenges in network meta-analysis.;Cipriani;Ann Intern Med,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation;Infection and Drug Resistance;2024-06

2. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity;Journal of Infection and Chemotherapy;2024-06

3. Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis;Clinical Microbiology and Infection;2024-05

4. Current status and new experimental diagnostic methods of invasive fungal infections after hematopoietic stem cell transplantation;Archives of Microbiology;2024-04-28

5. Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients;Bone Marrow Transplantation;2024-04-05